Evidence that the inhibitory effects of stress on reproduction in teleost fish are not mediated by the action of cortisol on ovarian steroidogenesis

Ovarian follicles of goldfish, common carp, and the sparid Pagrus auratus (New Zealand snapper) were incubated in vitro to assess the effects of cortisol (F) on ovarian steroidogenesis. Unstimulated goldfish follicles produced little testosterone (T) or 17 beta-estradiol (E2), whereas both carp and snapper follicles spontaneously produced E2 and to a lesser extent T. Goldfish follicles produced increased amounts of E2 in response to treatment with human chorionic gonadotropin (hCG), whereas carp and snapper follicles did not. However, stimulation of carp follicles with maturational carp gonadotropin (cGTH-II) resulted in dose-dependent increases in production of E2. Treatment of follicles of all three species with T resulted in E2 production to levels as high as or higher than those following treatment with hCG or cGtH-II. Cotreatment of follicles with T and hCG or cGTH-II did not result in higher E2 production than treatment with T alone. Goldfish follicles treated with 25-hydroxycholesterol showed increases in E2 production that were similar to those occurring following treatment with T. Treatment of follicles with F at a range of doses up to 1 microgram.ml-1 had no inhibitory effect on T or E2 production in any treatment combination in any of the species examined. In several cases, follicles incubated with T and/or hCG produced more E2 in the presence of F than they did without F. The results suggest either that the observed inhibitory effects of stress in a range of teleost species are not mediated by F or that they arise higher in the endocrine pathway than at the level of ovarian steroidogenesis.

Nature and distribution of gonadotropin-releasing hormone (GnRH) in the brain, and GnRH and GnRH binding activity in serum of the spotted dogfish Scyliorhinus canicula

The distribution of different molecular forms of gonadotropin-releasing hormone (GnRH) in the brain and serum of the spotted dogfish, Scyliorhinus canicula, was investigated by an indirect immunofluorescence method, using antisera against salmon (s-), chicken-II (cII-) and mammalian (m-) GnRHs, and by reverse-phase high-performance liquid chromatography (RP-HPLC) coupled with radioimmunoassays. Five GnRH molecular forms were demonstrated on the basis of the retention time in the RP-HPLC system. The characteristics of four of these GnRH peptides are consistent with those of m-, cII-, dogfish (df-), and sGnRH. The fifth form appears to be novel. Immunoreactive sGnRH structures were confined to the diencephalon; whereas cIIGnRH and mGnRH were found in the telencephalon and diencephalon. cIIGnRH- and dfGnRH-like molecules were detected in the serum. Moreover, a specific, low-affinity GnRH binding protein (GnRH-BP) was found in the serum of the spotted dogfish. The binding of [125I]sGnRHA to the serum GnRH-BP was dependent on incubation time, equilibrium being reached within 1 hr at 4 degrees; binding was rapid and completely reversible. Scatchard analysis yielded a linear plot with a Kd of 7.9 x 10(-7) M. The presence of a GnRH-BP in spotted dogfish serum suggests a probable action of GnRH via the general circulation.

Bombesin-like immunoreactivity in the forebrain and pituitary and regulation of anterior pituitary hormone release by bombesin in goldfish

The presence and distribution of bombesin (BBS)/gastrin-releasing peptide (GRP)-like immunoreactivity (IR) was examined in the goldfish pituitary and forebrain. BBS/GRP-like IR nerve fibres were consistently observed throughout the pituitary neurointermediate lobe (NIL); occasionally, BBS/GRP-like material was localized in cells and few fibres within the pars distalis. Within the goldfish forebrain, sparse, fine-beaded BBS/GRP-like IR fibres and few perikarya were detected in the preoptic hypothalamus. BBS/GRP-like IR material was also present in the ventro-posterior hypothalamus and the hypothalamic inferior lobes, and, in particular, within the nucleus lateral tuberis pars anterioris (NLTa) and nucleus lateral tuberis pars posterioris (NLTp), nucleus anterior tuberis (NAT), nucleus recessus lateralis (NRL), nucleus recessus posterioris (NRP), and the nucleus diffusus lobi inferioris (NDLI). Several BBS/GRP-like IR perikarya were observed in periventricular regions of the NLT, NRL, and NRP. Finally, BBS/GRP-like IR material was detected in the nucleus habenularis, the nucleus rotundus, several thalamic nuclei, and the optic tectum of the dorso-posterior diencephalon. The presence of BBS/GRP-like IR material within the preoptic hypothalamus, hypophysial stalk, and in the pituitary suggests that BBS-like peptides may regulate pituitary hormone release in fish. Perifusion of goldfish pituitary fragments with initial pulses of 0.1, 10, 100 or 1,000 nM BBS stimulated both growth hormone (GH) and gonadotropin (GtH-II) release. Repeated pulses of the same dose of BBS generally stimulated GH and GtH-II release to a similar magnitude. These studies provide initial evidence that BBS/GRP-like peptides are present within the central nervous system of teleost fish. The anatomical distribution of BBS/GRP-like IR in goldfish hypothalamic feeding center supports our previous report indicating a role for BBS in the central regulation of food intake in fish. Additionally, the presence of BBS/GRP-like IR material in the pituitary and brain areas associated with the regulation of anterior pituitary hormone secretion, as well as evidence demonstrating a direct action of BBS at the level of the goldfish pituitary to modify GH and GtH-II secretion, indicates that BBS/GRP-like peptides likely act to regulate pituitary hormone release in teleosts.

In vivo actions of a gonadotropin-releasing hormone (GnRH) antagonist on gonadotropin-II and growth hormone secretion in goldfish, Carassius auratus

In our previous in vitro studies, [Ac-delta 3-Pro1, 4FD-Phe2, D-Trp3,6]-mGnRH (analog E) suppressed both gonadotropin-II (GTH-II) and growth hormone (GH) release stimulated by sGnRH and cGnRH-II. In the present study analog E significantly inhibited the increases in plasma GTH-II levels stimulated by sGnRH in sexually mature female and sexually recrudescent goldfish. Treatment of goldfish with alpha-methyl-p-tyrosin methyl ester (alpha-MPT) inhibits dopamine synthesis and abolishes the inhibitory actions of dopamine on GTH-II release, resulting in a potentiation of the GTH-II response to sGnRH. Following alpha-MPT pretreatment, analog E significantly reduced basal plasma GTH-II levels, and suppressed both sGnRH and cGnRH-II actions on GTH-II release. Analog E also inhibited the increase in plasma GTH-II levels in sexually mature male goldfish exposed to the female sexual pheromone, 17 alpha, 20 beta-dihydroxy-4-pregnen-3-one (17 alpha 20 beta-P), demonstrating that the increase in plasma GTH-II levels is due to release of endogenous GnRH. Analog E significantly inhibited the increases in plasma GH levels stimulated by treatment with sGnRH. Implantation of estradiol pellets increases basal plasma GH levels and increases the GH responsiveness to sGnRH in sexually recrudescent goldfish; analog E also suppressed the increase in plasma GH levels stimulated by injection of sGnRH in estradiol-treated fish. Analog E suppressed basal GTH-II and GH levels in fish that were unhandled prior to injection; however, analog E was not effective in reducing basal plasma GTH-II or GH levels in experiments in which the fish were blood sampled or subjected to some experimental manipulation prior to injection of analog E. Analog E also suppressed basal levels of GTH-II in alpha-MPT-treated fish, suggesting that stress inhibition of GTH-II release may be mediated by the dopaminergic system. In summary, the results demonstrate that (i) analog E can suppress the actions of exogenous sGnRH and cGnRH-II on GTH-II and GH release in vivo, (ii) the GnRH system mediates, at least in part, the plasma GTH-II response in sexually mature male goldfish following exposure to the female sexual pheromone 17 alpha 20 beta-P, and (iii) endogenous GnRH peptides are important in the regulation of basal plasma levels of GTH-II as well as GH, particularly in low stress conditions.

CCK/gastrin-like immunoreactivity in brain and gut, and CCK suppression of feeding in goldfish

The presence and distribution of cholecystokinin (CCK)/gastrin-like immunoreactive (IR) material were examined in the goldfish brain and gut. In the forebrain, CCK/gastrin-like IR fibers and perikarya were localized to nuclei of predominantly the ventral telencephalon and diencephalon; more dorsal forebrain regions contained only few, thin-beaded, sparsely distributed IR fibers. CCK/gastrin-like IR was specifically detected in the preoptic hypothalamus, including the nucleus entopeduncularis, nucleus preopticus periventricularis, and nucleus preopticus. Of all brain regions examined, the highest concentration of CCK/gastrin-like IR staining was consistently observed in nuclei of the ventroposterior and inferior lobes of the hypothalamus. Within the gut, both nerve fibers and endocrine cells contained CCK/gastrin-like IR. The abundance of CCK/gastrin-like IR material within brain areas known to represent the feeding center of fish, as well as the presence of IR material within the gut, suggests that CCK may influence feeding behavior in fish. When injected either intraperitoneally or into the third brain ventricle into goldfish, sulfated CCK-8 (CCK-8s) suppressed food intake. The nonsulfated form of CCK-8 was not as effective as CCK-8s in suppressing feeding after intraperitoneal injection. No consistent changes were observed in circulating serum growth hormone or gonadotropin levels after either intraperitoneal or intracerebroventricular injection of CCK-8s. These studies demonstrate for the first time that CCK-8s is effective in acutely suppressing feeding behavior in fish when administered either peripherally or centrally into the third brain ventricle.

Episodic growth hormone secretion in the grass carp, Ctenopharyngodon idellus (C. & V.)

The secretory pattern of growth hormone (GH) was studied in sexually immature grass carp (0.5-1.0 kg body wt). Serial blood samples were taken at 15-min intervals during 4- to 6-hr sampling periods via a dorsal aorta cannula. During each 4- to 6-hr sampling period plasma GH profiles demonstrated episodic secretion. Two patterns were observed, consisting either of one episodic of GH secretion (single or several pulses clustered) or two episodes of GH secretion during each sampling period. The interval between the two episodes of GH secretion was 2.6 hr. This is the first demonstration of episodic GH secretion in a teleost.

Receptor binding of gonadotropin-releasing hormone antagonists that inhibit release of gonadotropin-II and growth hormone in goldfish, Carassius auratus

In goldfish, GnRH stimulates gonadotropin-II (GTH-II) and growth hormone (GH) release. The two native forms of GnRH, salmon GnRH (sGnRH) and chicken GnRH-II (cGnRH-II), bind to two classes of GnRH binding sites: high-affinity/low-capacity sites and low-affinity/high-capacity sites. Our previous in vitro perifusion studies of goldfish pituitary fragments showed that [Ac-delta 3-Pro1, 4FD-Phe2, D-Trp3,6]-mGnRH (analog E), [Ac-delta 3-Pro1, 4FD-Phe2, D-Trp3,6]-sGnRH (analog C), and [Ac-D(2)Nal1, 4Cl-D-Phe2, D-(3)Pal3,6]-cGnRH-II (analog N) inhibited both sGnRH- and cGnRH-II-stimulated GTH-II and GH release. Interestingly, analog C stimulated GH release but not GTH-II release. The objectives of the present study were 1) to test the site of action of GnRH antagonists in goldfish, 2) to test the relationship between receptor binding affinity of antagonists and their in vitro inhibitory potencies and apparent duration of action, and 3) to compare the binding characteristics of analog C with its differential action on GTH-II and GH release. As in previous studies, analog E suppressed sGnRH-stimulated GTH-II and GH release from perifused pituitary fragments. Similarly, analog E suppressed both sGnRH- and cGnRH-II-stimulated GTH-II and GH release from perifused dispersed goldfish pituitary cells, indicating the direct action of GnRH antagonists at the pituitary cell level. In the receptor binding studies, analog E displaced 125I-[D-Arg6, Pro9NHEt]-sGnRH (sGnRH-A) from crude goldfish pituitary membrane preparations in a dose-dependent manner.(ABSTRACT TRUNCATED AT 250 WORDS)

A new gonadotropin-releasing hormone (GnRH) superagonist in goldfish: influence of dialkyl-D-homoarginine at position 6 on gonadotropin-II and growth hormone release

The two native forms of gonadotropin-releasing hormones (GnRH) present in goldfish, salmon GnRH (sGnRH) and chicken GnRH-II (cGnRH-II), stimulate gonadotropin-II (GTH-II) and growth hormone (GH) release both in vivo and in vitro. In our previous study using perifused goldfish pituitary fragments, many mammalian GnRH antagonists, especially those with D-Arg6, showed weak to strong stimulation of GTH-II and GH release. In the present study, the dose-related stimulation of GTH-II and GH release by [Ac-D(2)-Nal1, 4Cl-D-Phe2, D-Trp3, D-Arg6, Trp7, D-Ala10] mGnRH (analog J) and [Ac-D(2)-Nal1, 4Cl-D-Phe2, D-Trp3, D-hArg(Et2)6, D-Ala10] mGnRH (analog K) was demonstrated; the stimulatory potency of both analogs was significantly lower than that of native sGnRH. In the presence of analogs J and K, cGnRH-II stimulated GTH-II release was significantly suppressed. Further, GTH-II and GH stimulation by 2 microM of analog K was significantly suppressed by a 'true' GnRH antagonist, [Ac-delta 3-Pro1, 4FD-Phe2, D-Trp3,6] mGnRH (analog E). These results indicate that analogs J and K increase GTH-II and GH release in goldfish by acting on GnRH receptors on gonadotrophs and somatotrophs. Since analog K, having [D-hArg(Et2)6], strongly stimulated GTH-II release, the potency of [D-hArg(Et2)6] or [D-hArg(CH2CF3)2(6)] substituted analogs to stimulate GTH-II and GH release from the perifused goldfish pituitary fragments was tested. Among the peptides tested, [D-hArg(Et2)6, Pro9-NHEt] sGnRH had a higher potency in stimulating GTH-II release than any other analog tested in the present or in previous studies. For stimulation of GH release, [D-hArg(Et2)6, Pro9-NHEt] sGnRH and [D-Arg6, Pro9-NHEt] sGnRH were the most potent analogs tested; analogs of mGnRH were less potent than sGnRH, indicating the importance of Trp7, Leu8 residues in the native peptide. These results suggest the importance of [D-Arg6] or alkylated [D-Arg6] in determining the intrinsic activity and potency of GnRH peptides in goldfish.

Activin-like peptides in somatotrophs and activin stimulation of growth hormone release in goldfish

Activin and inhibin, dimeric protein hormones originally isolated from mammalian gonads, are involved in the regulation of pituitary gonadotropin secretion. Using domain-specific antibodies against activin and inhibin alpha, beta A, and beta B subunits, the present study demonstrates that immunoreactive activin and inhibin subunits, especially beta A, exist in goldfish pituitary. Immunocytochemical staining with anti-gonadotropin-II and anti-growth hormone showed that the pituitary cells containing immunoreactive activin beta subunits are somatotrophs. This is different from the situation in mammals where it is the gonadotrophs that produce activin molecules within the pituitary. The staining with anti-beta B was overall weak compared to that with anti-beta A, but both appear to localize in the same cells. Strong immunostaining with the anti-inhibin alpha subunit was also observed in the goldfish pituitary; however, the immunoreactivity is dissociated from those of beta A and beta B, and mainly associated with nerve fibers in the neurointermediate lobe. Based on this evidence, it is suggested that the goldfish pituitary predominantly produced activin-like molecules. Both porcine activin and inhibin stimulate growth hormone release from perifused goldfish pituitary fragments. Taken together with our previous findings that porcine activin stimulates gonadotropin-II release in goldfish, and the fact that the somatotrophs and gonadotrophs are in close contact with each other in the goldfish pituitary, it is hypothesized that somatotroph-derived activin may exert paracrine actions on the adjacent gonadotrophs to stimulate gonadotropin release and autocrine actions on somatotrophs to stimulate growth hormone secretion. This also provides a mechanism for communication between these two pituitary cell types.

Biomechanical effects of internal fixation of the distal tibiofibular syndesmotic joint: comparison of two fixation techniques

This biomechanical study compares two methods of internal fixation of the tibiofibular syndesmosis used in Weber type C malleolar fractures of the ankle. The transverse syndesmotic 3.5-mm screw was compared with two 1.5-mm Kirschner wires introduced obliquely across the distal tibiofibular syndesmosis. The influence of implants on distal tibiofibular joint motion and contact characteristics of the intact ankle joint were determined. Up to 1.25 mm of lateral displacement and 2 degrees of external rotation of the lateral malleolus during uninjured ankle dorsiflexion was recorded. Both techniques stabilized the injured syndesmotic joint and limited its normal motion during flexion and extension of the ankle. Pressure distribution displaced laterally in internally stabilized ankles compared with intact specimens, regardless of the type of fixation used. Therefore, both techniques alter joint biomechanics equivalently compared with the intact ankle.

Differential actions of a mammalian gonadotropin-releasing hormone antagonist on gonadotropin-II and growth hormone release in goldfish, Carassius auratus

In goldfish the two native forms of gonadotropin-releasing hormone (GnRH), salmon GnRH (sGnRH) and chicken GnRH-II (cGnRH-II), stimulate both gonadotropin-II (GTH-II) and growth hormone (GH) release. Modifications of GnRH structure at positions 1, 2, 3, and 6 often result in an antagonist in goldfish, an observation well documented in mammalian studies. In a preliminary study in goldfish, a mammalian GnRH antagonist, [Ac-D(2)Nal1, 4Cl-D-Phe2, D(3)-Pal3,6, Arg5, D-Ala10]-mGnRH (analog L) weakly stimulated GTH-II release, and strongly inhibited GH release. The objectives of the present study were to study the dose-related actions of analog L on GTH-II and GH release in the goldfish, the specificity of inhibition of native GnRH actions, and to test whether analog L can act directly on goldfish pituitary cells. In a goldfish pituitary fragments perifusion system, analog L at different concentrations, given as 2-min pulses or as 30-min prolonged treatments, stimulated GTH-II and inhibited GH release in a dose-dependent manner. Analog L at 2 microM concentration (45 min) significantly suppressed sGnRH- and cGnRH-II-stimulated GTH-II as well as GH release. Analog L specifically inhibited GnRH-stimulated GH release, without having any significant effects on the GH release induced by either SKF38393, a dopamine D1 receptor agonist, or thyrotropin-releasing hormone. The GTH-II stimulatory and GH-inhibitory actions of analog L were significantly suppressed by a 'true' GnRH antagonist (Ac-delta 3-Pro1, 4FD-Phe2, D-Trp3,6)-mGnRH. Further, analog L stimulated GTH-II release and suppressed GH release from the enzymatically dispersed goldfish pituitary cells, indicating the direct actions of analog L at the pituitary cell level. Analog L also displaced 125I-(D-Arg6, Pro9 NHEt)-sGnRH bound to crude goldfish pituitary membrane preparations in a dose-related manner. In conclusion, contrary to its action as a potent GnRH antagonist in mammals, analog L has GTH-II stimulatory action in goldfish. Analog L by acting via GnRH receptors at the pituitary cell level differentially acts on GTH-II and GH release, suggesting functional differences in the properties of the GnRH receptors on GTH and GH cells. Analog L also specifically inhibits sGnRH and cGnRH-II actions on GTH-II and GH release.

Functional evidence regarding receptor subtypes mediating the actions of native gonadotropin-releasing hormones (GnRH) in goldfish, Carassius auratus

In goldfish, two native gonadotropin-releasing hormone (GnRH) peptides, salmon GnRH (sGnRH) and chicken-II GnRH (cGnRH-II), stimulate gonadotropin (GTH-II) and growth hormone (GH) secretion. In the present study we tested whether sGnRH and cGnRH-II act through different or the same population of GnRH receptors on GTH and GH cells, using various approaches. A GnRH antagonist [Ac-delta 3-Pro1,4FD-Phe2,D-Trp3,6]sGnRH (analog C) equally inhibited GTH-II release by sGnRH and cGnRH-II. Similarly, [Ac-D(2)Nal1,4Cl-D-Phe2,D-(3)Pal3,6]cGnRH-II (analog N) suppressed GTH-II stimulation by the two GnRH peptides equally. Further, in the continued presence of 100 nM sGnRH, a 100 nM pulse of cGnRH-II failed to cause additional GTH-II release and vice versa. Prolonged exposure of pituitary fragments to 100 nM sGnRH or cGnRH-II resulted in desensitization and reduced the GTH-II response to a subsequent pulse of either sGnRH or cGnRH-II equally. All these results indicate that both sGnRH and cGnRH-II act through the same population of GnRH receptors on gonadotrophs. Similarly, the GH responses obtained with (i) analog N treatment, (ii) pulse challenge to cGnRH-II during prolonged sGnRH treatment and vice versa, and (iii) desensitization studies suggest that both sGnRH and cGnRH-II act through the same population of GnRH receptors on somatotrophs. However, the properties of GnRH receptors on GTH-II and GH cells are different. Analog C stimulated GH release but not GTH-II release. In contrast, [Ac-delta 3-Pro1,4FD-Phe2,D-Trp3,D-Arg6]mGnRH stimulated GTH-II release but weakly suppressed GH release. These results indicate that sGnRH and cGnRH-II act on the same population of receptors on GTH cells and on a functionally distinct population of receptors on GH cells.

Neuropeptide-Y gene expression in the goldfish brain: distribution and regulation by ovarian steroids

Neuropeptide-Y (NPY) has been recently cloned from a goldfish cDNA library. Using a probe derived from this cDNA clone, the distribution and regulation of NPY mRNA in the goldfish brain were examined in the present study by in situ hybridization, Northern blot analysis, and ribonuclease protection assay. Frozen tissue sections from the goldfish brain and pituitary were hybridized with a digoxigenin-labeled RNA probe. Hybridization signal was detected mainly in fore-brain regions, particularly in the nucleus entopeduncularis of the ventral telencephalon, the preoptic area (POA), the olfactory bulbs, and various thalamic regions. In the midbrain, NPY mRNA was found in the optic-tectum and locus coeruleus. Northern blot hybridization of total RNA extracted from different brain areas with a 32P-labeled RNA probe detected a single mRNA species and confirmed that most NPY mRNA was present in telencephalon/POA and optic-tectum/thalamus. Our previous physiological studies showed that the ovarian steroids testosterone (T) and estradiol (E2) have potentiating effects on the actions of NPY on gonadotropin and GH release. Therefore, we also tested the possibility that T and E2 may modulate NPY gene expression. Fish were implanted ip with pellets containing T, E2, or no steroid (control) for 5 days, RNA was extracted, and NPY mRNA levels were estimated using a ribonuclease protection assay. Pretreatment with T or E2 induced a 2- to 3-fold increase in NPY mRNA levels in the telencephalon/POA, but not in the optic-tectum/thalamus. In situ hybridization using brains taken from T-implanted fish demonstrated that the site of steroid action is the POA. This report represents the first study on NPY gene expression in a nonmammalian species and demonstrates that 1) NPY mRNA is present in the neuroendocrine regulatory centers; and 2) ovarian steroids stimulate NPY gene expression in the POA.

Regional distribution and in vitro secretion of salmon and chicken-II gonadotropin-releasing hormones from the brain and pituitary of juvenile and adult goldfish, Carassius auratus

The content of salmon (sGnRH) and chicken-II (cGnRH-II) gonadotropin-releasing hormones was measured in discrete brain regions and pituitaries of juvenile and postspawning adult goldfish, using specific radioimmunoassays. In juveniles, the content of both peptides was low. sGnRH was the predominant form in telencephalon-preoptic area (T-POA) (sGnRH:cGnRH-II ratio = 2.06 +/- 0.66) and diencephalon (DIEN) (sGnRH:cGnRH-II ratio = 2.72 +/- 0.32), whereas cGnRH-II was predominant in cerebellum-brain stem (STEM) (sGnRH:cGnRH-II ratio = 0.47 +/- 0.05). Equal amounts of the two peptides were present in pituitary (PIT) (sGnRH:cGnRH-II ratio = 1.04 +/- 0.18). In adults, the content of both peptides in all regions was significantly increased. The increase in sGnRH exceeded that of cGnRH-II in T-POA and PIT, resulting in an increased sGnRH:cGnRH-II ratio in these tissues (T-POA, 3.55 +/- 0.26; PIT, 7.85 +/- 2.28). In DIEN and STEM, the increase in cGnRH-II content equaled or exceeded that of sGnRH; the sGnRH:cGnRH-II ratio was unchanged in STEM (0.39 +/- 0.06) and decreased in DIEN (1.23 +/- 0.13). The secretion of sGnRH and cGnRH-II was investigated under static in vitro incubation conditions. Both forms of the peptide were secreted from T-POA slices and PIT fragments from juvenile and adult fish. Secretion was significantly increased under potassium depolarizing conditions. Secretion of the two peptides was proportional to their content in tissues from both juvenile and adult goldfish.

An unusual arthroscopic discovery: an intraarticular schwannoma of the knee

This case report describes an unusual arthroscopic finding in a patient presenting with typical symptomatology of a medial meniscal tear of the right knee. Arthroscopy showed an multilobulated tumor that on histological examination was diagnosed as an intraarticular Schwannoma.

Seasonal variations in gonadotropin responsiveness, self-priming, and desensitization to GnRH peptides in the common carp pituitary in vitro

Seasonal variations of the GtH release response to salmon GnRH (sGnRH) and [D-Arg6,Pro9NEt]-sGnRH (sGnRH-A) were investigated in female common carp at different stages of the reproductive cycle using perifused pituitary fragments. The responsiveness to sGnRH and sGnRH-A varied seasonally in common carp pituitaries in vitro, with the greatest GtH release response in pituitaries from sexually mature (preovulatory) fish compared to pituitaries from sexually regressed fish. The magnitude of this seasonal change in the GtH release response was greater for sGnRH-A than for sGnRH, and sGnRH-A has a higher potency than sGnRH, particularly in pituitaries from sexually mature fish. Desensitization of perifused pituitary fragments to sGnRH and sGnRH-A, and a self-priming effect of sGnRH-A on the GtH release response, caused by repeated pulse administrations of the GnRH peptides, varied with the stage of reproductive cycle of the common carp. Using pituitaries from sexually regressed female common carp, desensitization occurred only when a high dose of sGnRH or sGnRH-A was given as repeated pulses at short time intervals, and no self-priming was observed by repeated administrations of sGnRH and sGnRH-A. Using pituitaries from sexually mature female common carp, desensitization occurred when a high dose of sGnRH and both high and low dosages of sGnRH-A were given as repeated pulses at short time intervals. Self-priming, largely due to the increase in basal GtH levels, occurred in response to repeated pulses of low dosages of sGnRH-A given at long intervals.

Bombesin acts to suppress feeding behavior and alter serum growth hormone in goldfish

The acute effects of a single injection of bombesin (BBS) on feeding behavior and serum growth hormone (GH) levels in goldfish were examined. When injected intraperitoneally (IP), BBS (0.5-100 ng/g) caused a dose-dependent decrease in food intake within 30 and 45 min of administration; maximal suppression was achieved at 50 ng/g BBS and was accompanied by an elevation in serum GH levels. Associated with IP injection of BBS was a pronounced spitting out behavior in which food pellets were taken into the oral cavity but immediately expelled. When injected into goldfish deprived of food for 72 h, 50 ng/g BBS was still potent in suppressing feeding behavior and increasing serum GH. Additionally, IP injection of BBS (10 or 100 ng/g) into groups of fish caused a significant increase in circulating serum GH levels at 1.5 h postinjection. Finally, when injected into the third brain ventricle (ICV), 60 ng/g BBS also caused a suppression in food intake and a concomitant increase in serum GH. Groups of fish injected ICV with 5 or 50 ng/g BBS also exhibited a graded increase in serum GH levels at 45 min postinjection. Overall, these data are the first to demonstrate in any lower vertebrate that a neuropeptide acts to suppress food intake and cause concomitant alterations in circulating serum GH levels, following either peripheral or central administration.

Interactions of somatostatin, gonadotropin-releasing hormone, and the gonads on dopamine-stimulated growth hormone release in the goldfish

Previously, we have demonstrated that dopamine (DA) stimulates growth hormone (GH) release from the goldfish pituitary through DA D1 receptors. In the present study, the role of DA as a GH-releasing factor was further examined in vitro by studying its interactions with other GH regulators in the goldfish. The GH-releasing effects of DA and salmon gonadotropin-releasing hormone (sGnRH) were found to be independent and additive at the pituitary cell level. Both the kinetics and the magnitude of DA-stimulated GH release were unaffected by simultaneous treatment with sGnRH and vice versa. Castration of sexually mature (or prespawning) goldfish significantly enhanced the DA-stimulated GH release, but at the same time reduced the GH responses to sGnRH. Furthermore, the GH responses to DA and the D1 agonist SKF38393 were totally abolished by somatostatin (SRIF), a known GH release inhibitor in the goldfish. These findings strongly indicate that SRIF, DA, sGnRH, and gonadal factors interact at the pituitary level to regulate GH release in the goldfish.

Identification of gonadotropin-releasing hormone and associated binding substances in the blood serum of a holocephalan (Hydrolagus colliei)

The identity of the gonadotropin-releasing hormone (GnRH) form and the presence of GnRH-binding substances in the blood serum of the holocephalan, spotted ratfish (Hydrolagus colliei), were investigated. The GnRH-like peptides in the serum were identified on the basis of relative hydrophobicity using reverse-phase HPLC. [His5,Trp7,Tyr8]GnRH (chicken GnRH-II) was the only GnRH form detected in the serum. It has been previously shown to be the only GnRH form in the brain of this species. The presence of GnRH-binding substances was inferred by anomalous HPLC elution of GnRH, ultrafiltration behavior, and by the direct binding of iodinated GnRH analogues by blood serum components. The mean GnRH concentration in the extracted blood serum was 125 +/- 11 pg ml-1 (n = 5) in males and 64 +/- 48 pg ml-1 (n = 4) and 155 +/- 26 (n = 4) in two separate groups of females. Measurement of GnRH in the blood serum is complicated by the presence of GnRH-binding substances, which may cause the coprecipitation of GnRH during extraction with organic solvents. The high concentration of GnRH and the presence of GnRH-binding substances suggest that systemic blood is the route by which GnRH reaches the gonadotropes and/or that GnRH may have a hormonal role in H. colliei.

Norepinephrine turnover in the goldfish brain is modulated by sex steroids and GABA

It is known that norepinephrine (NE) is important in the neuroendocrine control of pituitary gonadotropin II (GTH-II) and growth hormone (GH) release but very little is known about the factors regulating NE neurons in the goldfish brain. Female gonad-intact goldfish were implanted intraperitoneally (100 micrograms/g) with testosterone (T) or estradiol (E2) to elevate serum steroid levels. High-performance liquid chromatography measurements showed that steroid implantation had no effect on NE content in the telencephalon, including preoptic area (TEL-POA), or the hypothalamus (HYP). The turnover rate of NE was estimated from the rate of depletion of NE content from tissues following inhibition of tyrosine hydroxylase by alpha-methyl-p-tyrosine (240 micrograms/g). The present study demonstrates that E2 can decrease NE turnover rates in TEL-POA and HYP of sexually regressed goldfish (August). The results in recrudescent fish (November), however, indicate a more complex interaction of E2 with NE neurons since E2 increased NE turnover in TEL-POA and HYP in these animals. Testosterone (T) has less prominent effects on NE turnover rates in TEL-POA and HYP; the only significant effect of T-implantation was a small reduction of NE turnover in the TEL-POA of sexually recrudescent fish. Elevation of endogenous brain GABA concentrations by injection of the GABA transaminase inhibitor, gamma-vinyl-GABA (300 micrograms/g), significantly reduced NE turnover in TEL-POA. These data demonstrate that goldfish NE neurons in the TEL-POA are sensitive to regulation by changes in circulating sex steroids and by increases in brain GABA.

CCK/gastrin-like immunoreactivity in the goldfish pituitary: regulation of pituitary hormone secretion by CCK-like peptides in vitro

The presence and distribution of cholecystokinin (CCK)/gastrin-like immunoreactivity (IR) was examined in the goldfish pituitary. Intense CCK/gastrin-like IR was consistently observed within fibers of the proximal pars distalis (PD), with fewer IR fibers localized in the rostral PD. Within the proximal PD CCK/gastrin-like IR fibers were distributed among both the gonadotrophs and somatotrophs, suggesting a possible role for CCK-like peptides in the regulation of gonadotropin-II (GtH-II) and growth hormone (GH) secretion. Exposure of pituitary fragments from either sexually gonadal recrudescing (maturing) or regressed goldfish to three 5-min pulses of 1.0 or 10 nM sulfated CCK8 (CCK8-s), at 55-min interpulse intervals, resulted in an increased secretion of both GtH-II and GH. Independent of the dose perifused, the GtH-II release responses to the second and third pulses of CCK8-s were always of similar magnitude to the first pulse at a given dose. For GH, repeated challenges of pituitary fragments to 0.1 or 1.0 nM CCK8-s stimulated release responses of similar magnitude; however, successive pulses of 10 nM CCK8-s resulted in a desensitization in the GH release response to the second or the third pulse. Fragments from sexually regressed goldfish exhibited an overall greater release response of GtH-II to CCK8-s relative to fragments from sexually recrudescing fish, whereas the GH release responses to CCK8-s were similar between the two sexual stages. A dose-dependent release of GtH-II was present in pituitary fragments from sexually regressed goldfish following five 5-min pulses of increasing (0.1 to 100 nM) doses of CCK8-s. Finally, the sulfated forms of CCK8 and gastrin 17 (G17-s) exhibited greater stimulatory abilities than the nonsulfated form of CCK8 in releasing GtH-II and GH from fragments of sexually recrudescing fish. Additionally, CCK8-s and G17-s were equal in their capacity to stimulate the release of GtH-II, whereas G17-s was slightly more effective than CCK8-s in stimulating the release of GH. Overall, these studies are the first to provide evidence that IR CCK/gastrin-like fibers are codistributed among the gonadotrophs and somatotrophs, and that CCK-like peptides are highly effective in stimulating GtH-II and GH release from the goldfish pituitary.

In vitro characterization of gonadotropin-releasing hormone antagonists in goldfish, Carassius auratus

The two native forms of GnRH, salmon GnRH and chicken GnRH-II, in the brain and pituitary of goldfish are both active in stimulating gonadotropin-II (GTH-II) and GH release. The objective of the present study was to characterize GnRH antagonists for their ability to inhibit sGnRH- and cGnRH-II-induced GTH-II and GH release in goldfish using a pituitary fragments perifusion system. Contrary to expectations, putative GnRH antagonists with D-Arg6 stimulated GTH-II and GH release in nearly all cases. [Ac-delta 3-Pro1,4FD-Phe2,D-Trp3,6]mammalian (m) GnRH inhibited sGnRH- and cGnRH-II-stimulated GTH-II release in a dose-dependent manner, with ED50 values of 242 +/- 48 and 169 +/- 17 nM, respectively. [Ac-delta 3-Pro1,4FD-Phe2,D-Trp3,6]mGnRH also inhibited GH release stimulated by sGnRH (ED50, 128 +/- 74 nM) and cGnRH-II (ED50, 157 +/- 67 nM). The degree of inhibition was higher in sexually regressed fish compared to postspawning fish. [D-p-Glu1,D-Phe2,D-Trp3,6]mGnRH suppressed both sGnRH- and cGnRH-II-induced GTH-II release with ED50 values of 326 +/- 96 and 249 +/- 74 nM, respectively. [Ac-delta 3-Pro1,4FD-Phe2,D-Trp3,6]sGnRH inhibited sGnRH and cGnRH-II stimulated GTH-II release, but stimulated GH release. On the other hand, [Ac-D(2)-Nal1,4Cl-D-Phe2,D-(3)Pal3,6,Arg5,D-A la10]mGnRH weakly stimulated GTH-II release, but strongly inhibited basal GH release. These results indicate that [Ac-delta 3-Pro1,4FD-Phe2,D-Trp3,6]mGnRH has clear antagonistic activity on sGnRH and cGnRH-II stimulation of GTH-II and GH release in vitro. The differential actions of a few GnRH analogs on GTH-II and GH release indicate that the properties of the GnRH receptors on GTH and GH cells may be different. The amino acid in position 6 plays an important role in determining the nature of intrinsic activity of GnRH peptides, and substitution of D-Arg6 normally produces agonistic analogs.

Characterization of D1 receptors mediating dopamine-stimulated growth hormone release from pituitary cells of the goldfish, Carassius auratus

Previously, we demonstrated that dopamine (DA) stimulates GH release from the pituitary of goldfish, and this action is mediated by D1-like receptors. In the current study, we have provided evidence for the presence of D1-specific binding sites in the pituitary cells of goldfish. These D1-binding sites were found to be saturable, stereospecific, and selective for D1 ligands. The rank order of binding affinity of these D1-binding sites is (+)SCH23390 > SKF83566 >> (-)SCH23390 > domperidone > LY171555 >> serotonin. The association of these D1-binding sites with [3H]SCH23390, a D1-specific radioligand, was rapid, reversible, and exhibited a high binding affinity in the nanomolar range. The Kd values were estimated to be 33.7 +/- 8.5 nM for mixed populations of pituitary cells and 10.9 +/- 2.5 nM for pituitary cell preparations enriched with somatotrophs. Autoradiographic studies revealed that specific binding of [3H]SCH23390 was predominantly localized in the pars distalis, not in the neurointermediate lobe of the goldfish pituitary. Furthermore, these D1-binding sites in the goldfish pituitary cells could be functionally correlated with the GH-releasing actions of DA. Since these D1-binding sites exhibited the expected pharmacological properties of mammalian D1 receptors, we conclude that DA D1 receptors are present in the goldfish pituitary and are responsible for the mediation of DA D1-stimulated GH release. The apparent similarities of the D1 receptor pharmacology between goldfish and mammals also suggests that DA D1 receptors are highly conserved during vertebrate evolution.

GABA stimulation of gonadotropin-II release in goldfish: involvement of GABAA receptors, dopamine, and sex steroids

The involvement of gamma-aminobutyric acid (GABA) in regulation of pituitary gonadotropin-II (GTH-II) release was studied in the goldfish. Intraperitoneal injection of GABA (300 micrograms/g) stimulated an increase in serum GTH-II levels at 30 min postinjection. The GABAA receptor agonist muscimol (0.1-10 micrograms/g) stimulated GTH-II in a dose-dependent manner. Baclofen, a GABAB receptor agonist, had a small but significant stimulatory effect at 1 and 10 micrograms/g; the amount of GTH-II released in response to baclofen was significantly less (P < 0.05) than that released by muscimol. Pretreatment of goldfish with bicuculline, a GABAA receptor antagonist, but not saclofen, a GABAB receptor antagonist, blocked the stimulatory effect of GABA on serum GTH-II. Elevation of brain and pituitary GABA levels with the GABA transaminase inhibitor, gamma-vinyl-GABA (GVG), decreased hypothalamic and pituitary dopamine (DA) turnover rates, indicating that GABA may stimulate GTH-II release in the goldfish by decreasing dopaminergic inhibition of GTH-II release. The release of GTH-II stimulated by muscimol and GVG was potentiated by pharmacological agents that decrease inhibitory dopaminergic tone, indicating that DA may also inhibit GABA-stimulated GTH-II release. Based on the linear 24-h accumulation of GABA in brain and pituitary after GVG injection, implantation of testosterone, estradiol, or progesterone, previously shown to regulate the serum GTH-II release response to gonadotropin-releasing hormone and GABA, was also found to modulate GABA synthesis in the brain and pituitary.(ABSTRACT TRUNCATED AT 250 WORDS)

Differential distribution and response to experimental sexual maturation of two forms of brain gonadotropin-releasing hormone (GnRH) in the European eel, Anguilla anguilla

Using specific radioimmunoassays for the two GnRH molecular forms present in the European eel, Anguilla anguilla, (mGnRH and cGnRH II), we compared their distributions in the pituitary and different parts of the brain of female silver eels, as well as the modifications of their levels in experimentally matured female eels (treated with carp pituitary extract). In control eels, mGnRH levels were higher than cGnRH II levels in the pituitary, olfactory lobes and telencephalon, di- and mesencephalon, while the opposite was found in the posterior part of the brain (met- and myelencephalon). Experimental sexual maturation of the gonads significantly increased mGnRH levels in the pituitary and anterior parts of the brain; such a positive effect was not observed on the low cGnRH II levels, which were, in contrast, reduced. These data indicate that the positive feedback of gonadal hormones on GnRH, that we previously demonstrated, would specifically affect the mGnRH form. The differential distribution and control of mGnRH and cGnRH II suggest that these two forms have different physiological roles in the eel. The large increase in mGnRH during sexual maturation suggests the prime implication of this form in the neuroendocrine control of reproduction.

Dopamine functions as a growth hormone-releasing factor in the goldfish, Carassius auratus

In vivo and in vitro approaches have been used to examine the role of dopamine (DA) as a growth hormone (GH)-releasing factor in the goldfish. DA stimulated GH release from perifused pituitary fragments of goldfish in a dose-dependent manner. The GH-releasing effect of DA was seasonal, being the highest in sexually regressed fish, intermediate in recrudescent fish, and the lowest in sexually mature (prespawning) fish. The GH response to DA was blocked by the D1 antagonist (+)SCH23390, confirming the involvement of D1 receptors in DA-stimulated GH release. In studies using static incubation of pituitary cells, somatostatin, a known physiological GH-release inhibitor in the goldfish, abolished the GH response to DA. Intraperitoneal injection of apomorphine, a non-selective DA agonist, also increased the plasma GH levels and enhanced the linear body growth of goldfish. These results strongly suggest that DA, by acting through DA D1 receptors, functions as a GH-releasing factor in the goldfish.

The regulatory effects of thyrotropin-releasing hormone on growth hormone secretion from the pituitary of common carp in vitro

The effects of thyrotropin-releasing hormone (TRH) on growth hormone (GH) and gonadotropin (GtH) release, and the influences of somatostatin (SRIF), the dopamine agonist apomorphine (APO) and extracellular calcium on basal and TRH-induced GH release were examined using an in vitro perifusion system for pituitary fragments of common carp (Cyprinus carpio). Five minute pulses of different dosages of TRH stimulated a rapid and dose-dependent increase in GH release from the perifused pituitary fragments with an ED50 of 9.7 ± 2.3 nM. TRH was ineffective on GtH release. SRIF significantly inhibited basal and TRH-induced GH release from the perifused pituitary fragments, and the effects of SRIF were dose-dependent. APO induced a dose-dependent increase in basal and TRH-stimulated GH release from the perifused pituitary fragments. Increasing the concentrations of extracellular calcium from 0 mM to 1.25 mM resulted in an increase in basal and TRH-induced GH release. The high dose of calcium (6.25 mM) caused a slight decrease in basal and TRH-induced GH release compared with those at a concentration of 1.25 mM.

Cloning and sequencing of goldfish activin subunit genes: strong structural conservation during vertebrate evolution

Inhibin and activin are structurally related dimeric peptides sharing two distinct but related subunits, beta A and beta B. By using polymerase chain reaction (PCR), we have cloned and sequenced activin beta A and beta B genes encoding the mature region of the peptides from the goldfish genomic DNA. A single form of beta A and two forms of beta B subunits were found. There is high identity with mammalian counterparts; the goldfish beta A subunit has 78% protein sequence identity with human beta A subunit, and the two beta B subunits have more than 94% sequence identity with human beta B subunit. This is the first demonstration of the activin family of peptides in the fishes.

Actions of goldfish neuropeptide Y on the secretion of growth hormone and gonadotropin-II in female goldfish

Neuropeptide Y (NPY) has been recently characterized in the goldfish and the sequence deduced from goldfish brain cDNA clones reveals that goldfish NPY (gNPY) has over 86% identity with human NPY (hNPY) (Blomqvist et al., 1992, Proc. Natl. Acad. Sci. USA 89, 2350-2354). In the present study, we used synthetic gNPY to investigate the role of NPY in the regulation of growth hormone (GH) and gonadotropin-II (GtH-II) in the goldfish. The dose-response relationships of gNPY on GH and GtH-II release were first tested using an in vitro perifusion system for pituitary fragments. It was found that gNPY stimulated both GH and GtH-II release in a dose-dependent manner, with ED50 values of 1.89 +/- 0.9 nM for GH and 4.19 +/- 2.9 nM for GtH-II. In addition, the C-terminal fragment gNPY (18-36) stimulated the release of both GH and GtH-II, but with lower potency than did the intact molecule. These results confirm our previous findings using hNPY. The interactions of gNPY and other GH and GtH-II regulators were also examined in the present studies. Prolonged infusion of sGnRH induced initial peak releases of GH and GtH-II, followed by a second phase of sustained hormone release at a reduced level. Application of a 5-min pulse of gNPY during the second phase of sGnRH action further stimulated GH and GtH-II release, but only to the levels similar to those induced by gNPY alone. Prolonged infusion with gNPY induced a rapid desensitization of GH and GtH-II release; the hormone levels returned to basal within 25 min in the continued presence of gNPY. Administration of 5-min pulse of sGnRH during the desensitization phase of continuous gNPY perfusion induced a similar GH response to that induced by sGnRH alone, whereas the GtH-II responses to sGnRH given during gNPY infusion were smaller than the responses to sGnRH alone, suggesting that the mechanisms of gNPY stimulation on GH and GtH-II release may be somewhat different. The gNPY-induced GH release was blocked by somatostatin, a known GH inhibitor; the gNPY-induced GtH-II release was reduced by dopamine, a known inhibitor for GtH-II. Finally, intraperitoneal injection of gNPY induced time- and dose-dependent increases in serum GH and GtH-II levels. Together, these results suggest that NPY may play a physiological role in the regulation of GH and GtH-II secretion in the goldfish.

In vitro and in vivo evidence that dopamine exerts growth hormone-releasing activity in goldfish

We have previously demonstrated that dopamine (DA) and the DA D1 agonist SKF 38393 stimulate growth hormone (GH) release from perifused pituitary fragments of the goldfish, suggesting an involvement of DA D1 receptors in GH regulation. In the present study, the role of DA on GH release and body growth of the goldfish was further investigated both in vivo and in vitro. DA consistently stimulated GH release in a dose-dependent manner from perifused goldfish pituitary fragments. The GH-releasing action of DA was seasonal, being the highest in sexually regressed fish, intermediate in recrudescent fish, and the lowest in sexually mature (prespawning) fish. Somatostatin, a known GH-release inhibitor in the goldfish, suppressed basal GH release and abolished the GH response to DA in perifused pituitary fragments as well as pituitary cells under static incubation. Intraperitoneal administration of the nonselective DA agonist apomorphine and the D1 agonist SKF 82958 increased the plasma GH levels in the goldfish. These GH responses were blocked by simultaneous treatment with the D1 antagonist Sch 23390 but not the D2 antagonist pimozide. Apomorphine administered orally also induced a similar elevation in plasma GH levels. Long-term feeding with apomorphine was found to be stimulatory to the body growth of goldfish. These results provide evidence that the neurotransmitter DA, by acting through DA D1 receptors in the pituitary, also functions as a GH-releasing factor in the goldfish.

Seasonal variation of neuropeptide Y actions on growth hormone and gonadotropin-II secretion in the goldfish: effects of sex steroids

The effects of neuropeptide Y (NPY) on growth hormone (GH) and gonadotropin-II (GtH-II) release in different reproductive stages were studied using perifused pituitary fragments of female goldfish. The GH and GtH-II release responses to 5-min pulses of NPY were relatively small in sexually regressed fish (July), intermediate in recrudescent fish (December), and maximal in sexually mature (= prespawning) fish (May). To test if sex steroids can modulate NPY action, the effects of in vivo implantation of 17 beta-estradiol (E2) and testosterone (T) (both at 100 micrograms/g dosage) on NPY-induced GH and GtH-II secretion were examined. In sexually regressed goldfish, implantation of T significantly enhanced NPY-induced GH and GtH-II release from perifused pituitary fragments; implantation of E2 potentiated the NPY-induced GtH-II, but not GH release. However, steroid implantation did not affect responses to NPY when this experiment was repeated using pituitaries from sexually mature fish. To test the hypothesis that steroids may act directly at the level of the pituitary to potentiate NPY action, pituitary fragments taken from sexually regressed goldfish were incubated with 100 nM T for 24 h, and the GH and GtH-II responses to 5-min challenges of NPY assessed in the presence of T. Both GH and GtH-II responses to NPY were not affected by treatment with T in vitro, suggesting that T does not act directly at the level of the pituitary.(ABSTRACT TRUNCATED AT 250 WORDS)

[Fracture of the femoral neck: therapeutic approach]

The therapeutic approach for treatment of femoral neck fractures is reviewed. The choice of implant is dependent primarily on patient age and amount of fracture displacement. Hemiarthroplasty remains the treatment of choice for displaced femoral neck fractures in older or debilitated patients. Internal fixation is always indicated in healthy and active subjects, whether the fracture is displaced or undisplaced. Internal fixation with three cancellous screws provides good mechanical stability without compromising head vitality when compared to other implants.

Testosterone enhances GABA and taurine but not N-methyl-D,L-aspartate stimulation of gonadotropin secretion in the goldfish: possible sex steroid feedback mechanisms

The effects of gonadal steroids on GABA-, taurine (TAU)- and N-methyl-D,L-aspartate (NMA)-induced gonadotropin-II (GTH-II) release were investigated in male and female goldfish in vivo. In sexually regressed goldfish (both sexes mixed), intraperitoneal implantation for 5 to 10 days with solid Silastic pellets containing testosterone (100 micrograms/g), oestradiol (100 micrograms/g) or progesterone (100 micrograms/g) was previously shown to elevate serum sex steroid levels to values comparable to those in sexually mature animals, and to potentiate gonadotropin-releasing hormone-stimulated GTH-II release. In the present study, testosterone but not oestradiol or progesterone enhanced the stimulatory effects of exogenous GABA (100 micrograms/g) on GTH-II release in vivo. TAU (1 mg/g) stimulated GTH-II release in sexually regressed mixed sex and sexually recrudescent male goldfish, and both testosterone and oestradiol implantation enhanced GTH-II release induced by TAU. The glutamate agonist NMA (25 to 50 micrograms/g) was also found to stimulate GTH-II release; however it was relatively less effective in elevating serum GTH-II levels than GABA and TAU, and its effects were not modulated by sex steroid treatments. Pretreatment of goldfish with alpha-methyl-p-tyrosine to deplete brain and pituitary catecholamines did not affect NMA action on GTH-II release. Our results indicate that GABA, TAU and NMA are involved in the neuroendocrine regulation of GTH-II release in goldfish, and support the idea that testosterone participates in the positive feedback regulation of pituitary gonadotropin release in a non-mammalian vertebrate by enhancing GABA- and TAU-stimulated GTH release in vivo.

Neuropeptide-Y stimulates growth hormone and gonadotropin-II secretion in the goldfish pituitary: involvement of both presynaptic and pituitary cell actions

We have previously reported that neuropeptide-Y (NPY) stimulates GH and gonadotropin-II (GtH-II) release from perifused pituitary fragments in the goldfish. Since the teleost pituitary is directly innervated by neurosecretory terminals from the brain, we further investigated the possible sites of action of NPY. Both synthetic human NPY and NPY-(18-36), an agonist selective for the NPY Y2-receptor, stimulated GH and GtH-II release from the pituitary fragments; the magnitude of the response to NPY (18-36) was smaller than that to the whole molecule of NPY. NPY also stimulated the release of GH and GtH-II from perifused dispersed pituitary cells. In contrast, NPY-(18-36) had no effect on either GH or GtH-II release from dispersed pituitary cells. These data suggest that Y2 action is not direct at the level of pituitary cells, but may be indirect through actions on nerve terminals in the pituitary. The hypothesis that the action of NPY on GH and GtH-II release is mediated in part by GnRH was then tested. Both NPY and NPY-(18-36) stimulated the GnRH release from preoptic-anterior hypothalamic slices and pituitary fragments with similar potency. Furthermore, a GnRH antagonist significantly reduced the effects of NPY on both GH and GtH-II release in perifused pituitary fragments. Similar to previous findings, NPY, when given at 55-min intervals, desensitized the hormone responses in pituitary fragments. Similarly, the same treatment with NPY in perifused dispersed pituitary cells induced desensitization of GH and GtH-II responses. Together, these results suggest that 1) more than one type of NPY receptors are present in the goldfish pituitary; and 2) NPY has at least two sites of action in the pituitary. One site of action is the pituitary cells, where NPY directly stimulates GH and GtH-II secretion; the second is the nerve terminals, where NPY presynaptically stimulates GnRH release via Y2-like receptors, and GnRH, in turn, stimulates GH and GtH-II release.

Immunocytochemical evidence for the presence of inhibin and activin-like proteins and their localization in goldfish gonads

In previous studies, we have demonstrated that inhibin and activin are stimulatory to goldfish gonadotropin release. In the present study, the distribution of immunoreactive inhibin and activin subunits (alpha, beta A, and beta B) in goldfish gonads was examined with domain-specific antibodies against mammalian inhibin and activin subunits, using the avidin-biotin-peroxidase complex method. In the ovary, follicle cells surrounding the oocyte were heavily stained with anti-porcine beta A and human beta B subunits. The cytoplasm of previtellogenic oocytes, at all stages of the ovarian cycle, also showed strong reactions with anti-beta A and beta B. As ovarian recrudescence progressed, oocytes that started to accumulate cortical vesicles gradually lost their immunoreactivity, with the reaction intensity inversely proportional to the amount of cortical vesicles in the oocyte; when oocytes became full of cortical vesicles, the oocytoplasm was no longer immunoreactive to anti-beta A and beta B. The staining with antiporcine alpha subunit was similar to that with anti-beta A and beta B but the reaction intensity was weaker than that with anti-beta A and beta B. In the testis, the mature sperm in the tubular lumen exhibited a strong immunoreaction to anti-alpha antibody, while the interstitial tissue was completely negative. However, the immunoreactivities with anti-beta A and beta B in the testis were exclusively restricted to the interstitial tissues. These results provide evidence for the presence of inhibin and activin-like molecules in the goldfish and reveal the distribution of these molecules in the goldfish gonads.

Effects of sex steroid treatments on gonadotropin-releasing hormone-stimulated gonadotropin secretion from the goldfish pituitary

The effects of gonadal steroids on the gonadotropin (GTH) release response to salmon gonadotropin-releasing hormone (sGnRH), chicken gonadotropin-releasing hormone-II (cGnRH-II), and the sGnRH analogue, [D-Arg6, Trp7, Leu epsilon, Pro9]-N-ethylamide-GnRH (sGnRH-A), were investigated using an in vitro perifusion system for goldfish pituitary fragments. Gonad-intact male and female goldfish were implanted intraperitoneally (i.p.) with silastic pellets containing no steroid (blank), testosterone (T; 100 micrograms/g), or estradiol (E2; 100 micrograms/g); pituitaries were removed 5 days later for perifusion experiments. In vivo treatment with T or E2 potentiates sGnRH-, cGnRH-II-, and sGnRH-A-induced GTH secretion from pituitary fragments of sexually regressed and sexually recrudescent goldfish in vitro. Testosterone (100 nM; 24 h) treatment in vitro has a direct effect on the pituitary to increase sGnRH responsiveness, and this potentiating effect of T was blocked by the protein synthesis inhibitor cycloheximide (25 microM). In sexually regressed goldfish, in vivo T implantation enhanced the serum GTH response to sGnRH-A (0.01 microgram/g; 6 h) 7-fold. ED50 estimates for in vitro pituitary GTH responsiveness to sGnRH-A were 1.0 +/- 0.1 nM and 0.1 +/- 0.1 nM (p < 0.05) for blank and T-implanted groups, respectively. Radioligand (125I-sGnRH-A) binding studies demonstrated that enhanced pituitary responsiveness was independent of changes in pituitary GnRH receptor affinity or number. These results demonstrate that sex steroids increase pituitary sensitivity to GnRH peptides in the goldfish.

Growth hormone and gonadotropin secretion in the common carp (Cyprinus carpio L.): in vitro interactions of gonadotropin-releasing hormone, somatostatin, and the dopamine agonist apomorphine

The effects of salmon gonadotropin-releasing hormone (sGnRH) and the superactive agonist [D-Arg6, Pro9NEt]-sGnRH (sGnRH-A) on growth hormone (GH) and gonadotropin (GtH) release were examined using a perifusion system for pituitary fragments of the common carp (Cyprinus carpio). Perifusion of 2-min pulses of different concentrations of sGnRH or sGnRH-A stimulated a rapid and dose-dependent increase in GH release: ED50 values for sGnRH and sGnRH-A in stimulating GH release were 2.8 +/- 0.7 and 0.5 +/- 0.1 nM, respectively, indicating that the superactivity of sGnRH-A for stimulation of GtH release also applies in induction of GH release. Exposure of the pituitary fragments to 10 nM sGnRH or sGnRH-A alone resulted in increases in GH and GtH release on a similar temporal course. Apomorphine (10, 100, and 1000 nM) significantly inhibited basal and GnRH-induced GtH release in a dose-dependent manner and significantly stimulated basal GH release; however, APO did not enhance GnRH-induced GH release. Somatostatin (100 nM) significantly blocked basal release and 10 nM sGnRH- and sGnRH-A-induced GH release, but was ineffective on GtH release. Treatment with somatostatin (100 nM) in combination with apomorphine (100 nM) caused an increase in sGnRH-induced GH release compared to treatment with somatostatin alone; whereas, on GtH there was a significant decrease in basal and GnRH-induced levels, compared to treatment with somatostatin alone. These results indicate that GH release in common carp is regulated by somatostatin as GH release inhibitor. sGnRH and sGnRH-A act as GH-releasing factors; the mechanisms by which GnRH stimulates GH and GtH secretion are independent. The dopamine agonist apomorphine stimulates GH release and inhibits GtH release directly at the pituitary level.

Interactions of gonadal steroids with brain dopamine and gonadotropin-releasing hormone in the control of gonadotropin-II secretion in the goldfish

In goldfish it is known that intraperitoneal implantation with testosterone (T) or estradiol (E2) potentiates the serum gonadotropin-II (GtH-II) response to gonadotropin-releasing hormone (GnRH) without affecting basal GtH-II levels. Since the release of GtH-II in goldfish is under a tonic dopaminergic inhibitory tone, the possibility of sex steroids modulating brain and pituitary dopamine was examined in vivo and in vitro. Implantation of females with either T or E2 (100 micrograms/g in solid silastic pellets) also potentiated the increase in serum GtH-II in response to the dopamine antagonist, domperidone (10 micrograms/g). High-performance liquid chromatography measurements showed that steroid implantation had no effect on dopamine content in the telencephalon including preoptic area, hypothalamus, and pituitary. However, the present study demonstrates that T or E2 can increase pituitary dopamine turnover rates following tyrosine hydroxylase inhibition with alpha-methyl-p-tyrosine (240 micrograms/g). In vitro perifusion of pars distalis fragments from E2- or T-treated fish also showed a potentiation of salmon GnRH (sGnRH)-induced GtH-II release compared to controls. However, exposure to pituitary fragments from control and steroid-treated fish to increasing doses of the dopamine agonist LY 171555 did not demonstrate a significant difference in the sensitivity of the gonadotrophs to dopamine. Testosterone-induced alterations in DA turnover are dissociable from the positive action of T on pituitary responsiveness, since the potentiating effect of T implantation was not affected by severe depletion of brain and pituitary DA levels by alpha-methyl-p-tyrosine pretreatment. These data demonstrate that in gonad-intact goldfish, sex steroids enhance pituitary responsiveness to GnRH but basal serum GtH-II levels are maintained by a concomitant increase in DA turnover in the pituitary.

Influence of the reamer shape on intraosseus pressure during closed intramedullary nailing of the unbroken femur: a preliminary report

The generation of intramedullary pressure during reaming of the femur was compared for two different reamer systems: the AO/ASIF universal reamer and the Gray flexible reamer system (Howmedica), while reaming in 9 oncologic patients undergoing prophylactic nailing of metastatic femora as indicated by impending fractures (unbroken femora). An intracranial fibre optic catheter pressure-monitoring device inserted through the distal supracondylar cortex was used to perform measurements. Preliminary data are presented. Maximum pressures of up to 450 mmHg were recorded during reaming with the smaller 9.0 and 9.5 mm theta reamers. Rapid penetration of the reamer in both proximal and distal metaphyses caused much higher pressures than reaming the cortex of the diaphysis. Speed of penetration and volume of the reaming shaft were found to be important parameters. No significant differences between maximal pressures generated by the two types of reamers could be observed.

Interactions of estradiol with gonadotropin-releasing hormone and thyrotropin-releasing hormone in the control of growth hormone secretion in the goldfish

The effects of testosterone (T) and estradiol (E2) on serum growth hormone (GH) concentrations were investigated throughout the seasonal reproductive cycle of the female goldfish. Gonad-intact female goldfish were implanted intraperitoneally for 5 days with silastic pellets containing no steroid (blank), T(100 micrograms/g) or E2 (25-100 micrograms/g). In blank-implanted females, seasonal variations in serum GH were evident; maximal serum GH levels were found in spring while minimal GH levels were found in summer and early autumn. Implantation of E2-containing silastic capsules stimulated increases (2-4 times control) in serum GH levels throughout the reproductive cycle. Implantation of T did not affect serum GH at any time of the year. One possible mechanism by which E2 could exert its effects may be through alteration of pituitary sensitivity to GH-releasing factors. The decapeptide salmon gonadotropin-releasing hormone (sGnRH) is found in the brain and pituitary of goldfish and stimulates gonadotropin (GTH) and GH secretion. In contrast, thyrotropin-releasing hormone (TRH) stimulates GH, but not GTH, release from pars distalis fragments obtained from sexually regressed (ED50 = 5.7 +/- 3.8 nM; August) or sexually mature (ED50 = 0.53 +/- 0.28 nM; March) fish; in vivo E2 treatment resulted in a 3-fold increase in the in vitro GH response to TRH. Furthermore, E2 treatment increased sGnRH-stimulated GH release by approximately 4-fold. These results demonstrate that E2 but not T stimulates GH secretion throughout the reproductive cycle of female goldfish. Furthermore, sGnRH and TRH stimulate GH release in a teleost, and these stimulatory responses are enhanced by physiological levels of E2.

Effects of porcine follicular fluid, inhibin-A, and activin-A on goldfish gonadotropin release in vitro

Inhibin and activin are important reproductive regulators in mammalian species and have been demonstrated to be highly conserved in structure. The present study examines the effects of porcine follicular fluid (pFF; a crude inhibin and activin preparation) and purified porcine inhibin-A and activin-A on goldfish gonadotropin-II (GTH-II) release. In studies using primary cultures of dispersed goldfish pituitary cells in static incubation, treatments with pFF, inhibin-A, and activin-A for 10 h caused dose-dependent increase in GTH-II release. In perifusion studies using goldfish pituitary fragments, basal GTH-II release was significantly elevated after 12-h exposure to 500 micrograms/ml pFF. Furthermore, GnRH-induced GTH-II secretion was potentiated by pretreatment with pFF. When pFF was applied in the form of 5-min pulses, a rapid dose-related stimulation of GTH-II was observed. Similarly, challenges with 2-min pulses of 15, 150, and 1500 pM inhibin-A and activin-A stimulated GTH-II release by goldfish pituitary fragments in a rapid and dose-dependent manner. This acute stimulatory action of inhibin on goldfish GTH-II release was completely abolished after pretreatment with specific inhibin antibodies. The acute actions of inhibin and activin on GTH-II release are probably not due to the release of endogenous GnRH from nerve terminals in the pituitary fragments or binding to the GnRH receptors. First, a specific GnRH antagonist did not block the actions of inhibin and activin. Second, dopamine, a potent inhibitor of GnRH-stimulated GTH-II secretion in goldfish, was only partially effective in decreasing inhibin- and activin-induced GTH-II release. Third, the stimulatory effects of inhibin and GnRH on GTH-II release were additive. These lines of evidence also indicate that the mechanisms mediating inhibin and activin stimulation of goldfish GTH-II release may be somewhat different from those of GnRH. These results demonstrate that in contrast with the usual inhibitory effects of inhibin on GTH release in mammals, both inhibin and activin exert long term and acute stimulatory actions on GTH-II release in the goldfish.

Isolation and characterization of hypothalamic growth-hormone releasing factor from common carp, Cyprinus carpio

A growth hormone-releasing factor (GRF)-like peptide was isolated from the hypothalamus of common carp, Cyprinus carpio, by acid extraction, gel filtration chromatography, immunoaffinity chromatography using antiserum directed against rat GRF, and multiple steps of HPLC using octadecyl columns. Based on Edman degradation and peptide mapping, this teleost GRF was established to be a 45-residue peptide with the following primary structure: His-Ala-Asp-Gly-Met-Phe-Asn-Lys-Ala-Tyr-Arg-Lys-Ala-Leu-Gly-Gln-Leu-Ser- Ala-Arg - Lys-Tyr-Leu-His-Thr-Leu-Met-Ala-Lys-Arg-Val-Gly-Gly-Gly-Ser-Met-Ile-Glu- Asp-Asp-Asn-Glu-Pro-Leu-Ser. Carp GRF is closely related structurally to peptides of the glucagon-secretin superfamily, and more particularly to mammalian vasoactive intestinal peptide (VIP) precursors and the N-terminal portion of mammalian GRFs. A synthetic replicate of this peptide is highly potent [50% effective dose (ED50) approximately 0.08 nM] in stimulating GH release from cultured goldfish pituitary glands and in elevating serum GH levels 30 min after injection (0.1 micrograms/g) in goldfish.

Distinct sequence of gonadotropin-releasing hormone (GnRH) in dogfish brain provides insight into GnRH evolution

In vertebrates, gonadotropin-releasing hormone (GnRH) belongs to a family of decapeptides characterized by the conservation of residues 1, 2, 4, 9, and 10. In the jawed vertebrates only positions 5, 7, and 8 in the GnRH molecules vary. We have now purified two forms of GnRH from the brains of spiny dogfish (Squalus acanthias) by using reverse-phase high-performance liquid chromatography. The primary structures were established by automated Edman degradation and mass spectral analysis. The distinct structure of the first form (dogfish GnRH) is pGlu-His-Trp-Ser-His-Gly-Trp-Leu-Pro-Gly-NH2 (pGlu represents pyroglutamyl). The second peptide is identical to a form of GnRH originally isolated from chicken brains (chicken GnRH-II; pGlu-His-Trp-Ser-His-Gly-Trp-Tyr- Pro-Gly-NH2) and is widespread throughout the vertebrates. We are aware of no other species of cartilaginous fish in which the primary structures of two forms of GnRH have been determined. The presence of chicken GnRH-II in dogfish supports the idea that chicken GnRH-II is the oldest GnRH to evolve in jawed vertebrates. With the addition of the dogfish GnRH structure to the family, two main structural branches of GnRH can be delineated. The physiological effects of dogfish GnRH included the release of not only gonadotropin but also growth hormone from goldfish pituitary fragments.

Amino Acid Neurotransmitters and Dopamine in Brain and Pituitary of the Goldfish: Involvement in the Regulation of Gonadotropin Secretion

An isocratic high-performance liquid chromatographic technique was developed to measure levels of gamma-aminobutyric acid (GABA), glutamate, and taurine in the brain and pituitary of goldfish. Accuracy of this procedure for quantification of these compounds was established by evaluating anesthetic and postmortem effects and by selectively manipulating GABA concentrations by intraperitoneal administration of the glutamic acid decarboxylase (GAD) inhibitor 3-mercaptopropionic acid or the GABA transaminase inhibitor gamma-vinyl GABA. The technique provided a simple, rapid, and reliable method for evaluating the concentrations of these amino acids without the use of complex gradient chromatographic systems. To investigate the relationship between neurotransmitter amino acids and the control of pituitary secretion of gonadotropin, the effects of injection of taurine, GABA, or monosodium glutamate on GABA, glutamate, taurine, and, in some instances, monoamine concentrations in the brain and pituitary were evaluated and related to serum gonadotropin levels. Injection of taurine caused an elevation in serum gonadotropin concentrations. In addition, injection of the taurine precursor hypotaurine but not the taurine catabolite isethionic acid elevated serum gonadotropin levels. Intracerebroventricular injection of either GABA or taurine also elevated serum gonadotropin concentrations. Pretreatment of recrudescent fish with alpha-methyl-p-tyrosine reduced pituitary dopamine concentrations and also potentiated the serum gonadotropin response to taurine. Injection of monosodium glutamate caused an increase of glutamate content in the pituitary at 24 h; this was followed by a decrease at 72 h after administration. Pituitary GABA, taurine, and dopamine concentrations underwent a transient depletion after monosodium glutamate administration, and this was associated with an elevation of serum gonadotropin content.(ABSTRACT TRUNCATED AT 250 WORDS)

A reduction in pituitary dopamine turnover is associated with sex pheromone-induced gonadotropin secretion in male goldfish

In goldfish, the gonadal steroid, 17 alpha,20 beta-dihydroxy-4-pregnen-3-one (17,20 beta-P), functions as a potent preovulatory female sex pheromone which stimulates rapid elevations in serum gonadotropin (GtH) levels and subsequent increases in milt production in males. GtH secretion in goldfish is known to be regulated by the stimulatory actions of gonadotropin-releasing hormone (GnRH) and the inhibitory actions of dopamine (DA). This study specifically examined whether the 17,20 beta-P-induced elevation in male GtH is caused by pheromone-mediated changes in DA inhibition at the level of the pituitary. First, we have demonstrated that dihydroxyphenylacetic acid (DOPAC) is the primary metabolite of DA catabolism in the brain and pituitary gland of goldfish. Second, we measured changes in circulating levels of GtH and changes in pituitary content of DA and its metabolite, DOPAC, as well as possible alterations in DA turnover rate (DOPAC/DA ratio) following short-term exposure of male goldfish to water-borne 17,20 beta-P. Water-borne 17,20 beta-P consistently increased serum GtH levels in males within 20 min of exposure and maintained elevated levels for up to 120 min. Although changes in pituitary DA content were not observed during periods of high GtH release, coincident reductions in pituitary levels of DOPAC were measured within 45 min of exposure to the pheromone. More importantly, there was a significant decrease in the rate of DA turnover in the pituitary, as assessed by comparing the ratio of DOPAC to DA present, at 20, 45, and 120 min of exposure. Since the reduction of DA turnover in the pituitary is inversely correlated with periods of increased GtH release, the present results suggest that water-borne 17,20 beta-P causes an abatement of DA release to the pituitary. Based on the latency of the GtH response to water-borne 17,20 beta-P, a rapid reduction of DA turnover in the pituitary appears to be at least part of the neuroendocrine trigger for 17,20 beta-P-induced GtH release in male goldfish.

Influence of GABA on gonadotrophin release in the goldfish

The influence of GABA on pituitary gonadotrophin (GTH) release in the goldfish was studied by means of in vivo and in vitro techniques. It was found that GABA injected intraperitoneally caused an increase of serum GTH levels in regressed or early maturing fish, but not in late maturing animals. Moreover, injection of a GABA transaminase inhibitor caused a significant increase of GABA within the hypothalamus and pituitary, and a dose-dependent increase in serum GTH levels. To determine if this effect could be exerted directly at the level of the pituitary, dispersed pituitary cells in static incubation or in perifusion were exposed to increasing concentrations of GABA or its agonists muscimol and baclofen. None of these drugs was able to modify the spontaneous or GnRH-induced secretion of GTH, indicating that the in vivo effect of GABA was most likely mediated via another hypothalamic factor. Using in vitro incubation of pituitary slices, it was found that GABA caused a dose-related stimulation of GnRH release at the level of the pituitary, providing a possible explanation for the observed in vivo stimulatory effect of GABA on GTH release. Since the seasonal effect of GABA in vivo indicated a possible interaction of GABA with sexual steroids, GABA was given intraperitoneally to female goldfish implanted with either testosterone or estradiol. We found that the stimulatory effect of GABA on GTH release was abolished in estradiol-treated females but was still observed in testosterone-implanted fish. Moreover, estradiol but not testosterone caused a decrease of the GABA concentration within the telencephalon.(ABSTRACT TRUNCATED AT 250 WORDS)

Dopamine stimulates growth hormone release from the pituitary of goldfish, Carassius auratus, through the dopamine D1 receptors

Previously, we have demonstrated that ip injection of apomorphine, a nonselective dopamine (DA) agonist, increases serum GH levels in the goldfish, suggesting a possible role of DA in GH regulation. In the present study, the effects of DA on GH release in the goldfish were further characterized using an in vitro perifusion system for pituitary fragments. DA increased GH release in a dose-dependent manner with an ED50 of 0.26 +/- 0.06 microM. SKF38393, a DA D1 agonist, mimicked the GH-releasing effect of DA with an ED50 of 0.41 +/- 0.12 microM. Stereoselectivity consistent with mammalian DA D1 systems was demonstrated for the GH response to SKF38393; only the (+)- but not (-)-enantiomer of SKF38393 induced a dose-dependent GH release. Two other D1 agonists, SKF77434 and SKF82958, were also found to have GH-releasing activity. In contrast, high doses (up to 1 microM) of the DA D2 agonists, bromocriptine and LY171555, did not affect basal GH levels. The receptor specificity for DA-stimulated GH release was further investigated by using D1 and D2 antagonists; the D1 antagonists SCH23390 and SKF83566 completely abolished the GH response to DA or the D1 agonist SKF38393, whereas the D2-specific antagonists domperidone and (-)-sulpiride were not effective in this respect. Taken together, the present study demonstrates that DA is stimulatory to GH release from the pituitary of goldfish, and its action is mediated through receptors resembling the mammalian DA D1 receptors. The apparent similarities of the DA D1 receptor pharmacology between the goldfish and the mammals also indicate that D1 receptor is highly conserved during vertebrate evolution.

Activity of vertebrate gonadotropin-releasing hormones and analogs with variant amino acid residues in positions 5, 7 and 8 in the goldfish pituitary

All non-mammalian vertebrates as well as marsupial mammals have two or more forms of gonadotropin-releasing hormone (GnRH) in the brain. Goldfish brain and pituitary contains two molecular forms of GnRH, salmon GnRH ([Trp7, Leu8]m-GnRH; s-GnRH) and chicken GnRH-II ([His5, Trp7, Tyr8]m-GnRH; cII-GnRH). Both sGnRH and cII-GnRH stimulate gonadotropin (GtH) as well as growth hormone (GH) release from the goldfish pituitary. The purpose of the present study was to study the activity of the five known forms of GnRHs as well as analogs of mammalian GnRH (m-GnRH) with variant amino acid residues in positions 5, 7 and 8 in terms of binding to GnRH receptors, and release of GTH and GH from the perifused fragments of goldfish pituitary in vitro. All five vertebrate GnRH peptides stimulated both GtH and GH release in a dose-dependent manner, although their potencies were very different. cII-GnRH was somewhat more active than s-GnRH in releasing GtH, whereas s-GnRH tended to have a greater potency than cII-GnRH in terms of GH release. Both chicken GnRH-I (cI-GnRH) and lamprey GnRH (l-GnRH) were significantly less potent than mGnRH, s-GnRH and cII-GnRH in releasing GtH and GH. cII-GnRH binds with higher affinity for the high affinity binding sites compared to all other native peptides. The activity of [Trp7]-GnRH was similar to both s-GnRH and cII-GnRH in releasing GtH and GH. Substitution of His5 resulted in a significant decrease in GtH releasing potencies compared to mGnRH, sGnRH and cII-GnRH. [His5]-GnRH also had lower GH releasing potency than mGnRH and sGnRH. Tyr8, His8 and Leu8 substitutions caused significant decreases in GtH releasing potencies compared to mGnRH, s-GnRH and cII-GnRH, but did not cause a significant change in GH releasing potency. The combination of [His5, Trp7]-GnRH had GtH and GH releasing activities similar to m-GnRH, s-GnRH and cII-GnRH.(ABSTRACT TRUNCATED AT 400 WORDS)

Properties of common carp gonadotropin I and gonadotropin II

Two gonadotropins, GtH I and GtH II, were extracted with 35% ethanol-10% ammonium acetate, pH 6.1, from female common carp pituitary glands and purified by ion-exchange chromatography on a DE-52 column followed by gel filtration on a Sephadex G-75 column. Molecular weights of GtH I and GtH II as determined by SDS-PAGE were 45,000 and 35,000, respectively. Both GtHs dissociate into two subunits following reduction with beta-mercaptoethanol. These subunits contain different N-terminal amino acids (Tyr and Gly for GtH I; Tyr and Ser for GtH II). GtH I was acid stable and did not dissociate into subunits following treatment with 0.1% trifluoroacetic acid; GtH II readily dissociated into subunits by this treatment. GtH I and GtH II have distinct elution profiles on reverse-phase HPLC. The N-terminal amino acid sequence of the beta-subunit of GtH II was identical to that of common carp maturational GtH described by other workers suggesting that GtH I is a newly identified molecule. This was supported by radioimmunoassay analysis. GtH II and a common carp maturational GtH preparation (F11 cGtH; Peter et al., 1982, J. Interdiscipl. Cycle Res. 13, 229-239) had similar immunological activity in tests with antisera to the beta-subunit of maturational GtH whereas GtH I had low (less than 6%) cross-reactivity. GtH I, GtH II, and F11 cGtH were equipotent in tests with antisera to the alpha-subunit of maturational GtH suggesting these molecules contain a similar alpha-subunit. In vitro bioassays using goldfish revealed that GtH I and GtH II share the same spectrum of biological activities causing stimulation of ovarian and testicular steroidogenesis and induction of oocyte final maturation. The demonstration of two chemically distinct GtHs in common carp is similar to what has been described for chum and coho salmon.